RVMD Revolution Medicines Corp Yalpi rentabellik

RevMed (RVMD) kompaniyasining rasmiy ramzlari

Revolution Medicines (RVMD) kompaniyasiga investitsiya kiritish klinik sinovlarning muvaffaqiyatsizligi va barqaror daromad oqimlarining yo'qligi risklarini hamda o'z ichiga oladi. Biznesning muvaffaqiyati FDA tomonidan RAS inhibitorlarining tasdiqlanishiga va naqd pul sarflash sur'atiga bog'liq. Kompaniyaning yalpi foyda marjasi maqsadli terapiyaning samaradorligini namoyish etadi, 90.30 ko'rsatkichi esa innovatsion dori vositalarining salohiyatini baholash uchun maqsadli daraja vazifasini o'taydi.

Revolution Medicines Corp (RVMD) Yalpi foyda bo'yicha rentabellik: 04.07.2022 - 20.11.2026 davri uchun

Revolution Medicines Inc (RVMD) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:RevMed
Revolution Medicines, Inc. seriyali mahsuloti

Yalpi marja bevosita ishlab chiqarish xarajatlarini qoplashdan keyin qolgan tushum qismini aniqlash orqali foyda generatsiyasi samaradorligini o'lchaydi. Yalpi foyda marjasini tahlil qilish orqali investor biznesning narx belgilash imkoniyatlarini baholaydi, bu esa dori ishlab chiqarish va klinik sinovlarni o'tkazishda tashqi shartnomaviy tadqiqot tashkilotlariga (CRO) to'liq bog'liqligi sababli Revolution Medicines (RVMD) uchun juda muhimdir.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Sotuvning yalpi rentabelligi AAPG (Ascentage Pharma Group)|Yalpi marja CGON|UroGen Pharma - Sotuvning yalpi rentabelligi|Bicara Therapeutics - Yalpi foyda bo'yicha rentabellik|Yalpi marja Personalis Inc PSNL|Erasca Oncology - Yalpi marja|Yalpi foyda normasi DCTH (Delcath Corp)|YMAB: Yalpi marja|AURA - Yalpi foyda bo'yicha sotuv rentabelligi|CADL (Candel Therapeutics Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik